The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
SOHO 2026 | Updates on advances in geriatric assessment and treatment in DLBCL for older patients
Pallawi Torka, MD, Memorial Sloan Kettering Cancer Center, New York, NY, comments on advances in geriatric assessment and treatment in older patients with diffuse large B-cell lymphoma (DLBCL), noting significant progress since 2023, particularly in developing new agents such as bispecific antibodies for unfit older patients. This interview took place at the 14th Annual Meeting of the Society of Hematologic Oncology (SOHO 2026) in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
